Efficacy of a Low-Molecular-Weight Heparin (Bemiparin) in the Treatment of Chronic Foot Ulcers in Diabetic Patients

This study has been terminated.

Sponsor:

Collaborators:

Carlos III Health Institute

Rovi Pharmaceuticals Laboratories

Information provided by:

Spanish National Health System

ClinicalTrials.gov Identifier:

NCT00399425

First received: November 13, 2006

Last updated: NA

Last verified: November 2006

History: No changes posted

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	April 2004
Estimated Primary Completion Date:	No date given